Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers

NCT02033668 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrophy, Geographic

Interventions

DRUG: GSK933776 for SQ administration
DRUG: GSK933776 for IM administration
DRUG: GSK933776 for IV administration

Sponsor

GlaxoSmithKline

Collaborators

[object Object]